Clincosm LogoSign in Get a demo

kidney cancer

Showing 51 - 75 of 405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Cancer, Renal Cell Carcinoma Trial in United States (Ceevra Reveal)

Completed
Has Results
  • Kidney Cancer
  • Renal Cell Carcinoma
  • Ceevra Reveal
  • Santa Monica, California
  • +5 more
Jul 19, 2022

Kidney Cancer, Renal Cell Carcinoma, Unresectable Renal Cell Carcinoma Trial in United States (Talazoparib, Axitinib)

Recruiting
  • Kidney Cancer
  • +3 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 8, 2022

Kidney Cancer Trial in Birmingham (Acarbose Tablets)

Not yet recruiting
  • Kidney Cancer
  • Acarbose Tablets
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 2, 2022

Psychological Stress, Cardiopulmonary Bypass Surgery, Coronary Artery Bypass Surgery Trial in Italy, Netherlands, Spain (SaMD

Completed
  • Psychological Stress
  • +10 more
  • SaMD CARINAE
  • Ancona, Italy
  • +4 more
Jul 29, 2022

Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics System)

Not yet recruiting
  • Renal Cancer
  • +4 more
  • HistoSonics System
  • (no location specified)
Jul 26, 2022

Esophageal Cancer, Kidney Cancer, Larynx Cancer Trial in Saint Louis (Balloon-tipped catheter)

Not yet recruiting
  • Esophageal Cancer
  • +12 more
  • Balloon-tipped catheter
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 19, 2022

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting
  • ccRCC
  • +4 more
  • Los Angeles, California
  • +24 more
Jul 18, 2022

Percutaneous Cryoablation of Central Kidney Tumours With

Recruiting
  • Kidney Cancer
    • Strasbourg, France
      Service d'Imagerie Interventionnelle - CHU de Strasbourg - Franc
    Jul 15, 2022

    IRIS,Three-dimensional Anatomical Modeling Software for

    Recruiting
    • Kidney Cancer
    • IRIS 1.0
    • Edison, New Jersey
    • +1 more
    Jul 12, 2022

    Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

    Active, not recruiting
    Has Results
    • Kidney Cancer
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jun 21, 2022

    Marathon of Hope Cancer Centres Network Study for Ontario

    Recruiting
    • Breast Cancer
    • +11 more
      • Toronto, Ontario, Canada
        Princess Margaret Cancer Centre
      Jun 6, 2022

      International REgistry of COnservative or Radical Treatment of

      Recruiting
      • Kidney Cancer
      • Partial Nephrectomy (PN)
      • +3 more
      • Los Angeles, California
      • +36 more
      May 2, 2022

      Describe Kidney Cancer Patient Population Treatment, and Results

      Not yet recruiting
      • Renal Cell Cancer
      • +6 more
        • (no location specified)
        May 2, 2022

        Prostate Cancer, Bladder Cancer, Kidney Cancer Trial in New Brunswick (Body Mind Training (BMT), Body Training (BT):, Usual Care

        Recruiting
        • Prostate Cancer
        • +8 more
        • Body Mind Training (BMT)
        • +2 more
        • New Brunswick, New Jersey
          Rutgers University
        Apr 28, 2022

        Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

        Recruiting
        • Astrocytoma
        • +22 more
        • Kogarah, New South Wales, Australia
        • +1 more
        Apr 18, 2022

        DS Titanium Ligation Clip in Urology

        Completed
        • Prostate Cancer
        • +7 more
          • Offenburg, Germany
            Ortenau Klinikum Klinik für Urologie und Kinderurologie
          Apr 11, 2022

          Breast Cancer, Bladder Cancer, Kidney Cancer Trial in New York (PCR/PCR/LDR Strategy)

          Recruiting
          • Breast Cancer
          • +6 more
          • PCR/PCR/LDR Strategy
          • New York, New York
            Memorial Sloan Kettering Cancer Center
          Apr 1, 2022

          Kidney Cancer, Renal Cell Carcinoma Trial in New Brunswick, New York, Cleveland (Cabozantinib, Nivolumab, Cytoreductive

          Recruiting
          • Kidney Cancer
          • Renal Cell Carcinoma
          • New Brunswick, New Jersey
          • +2 more
          Mar 22, 2022

          Kidney Cancer Trial in Boston (NeoVax, Ipilimumab)

          Recruiting
          • Kidney Cancer
          • Boston, Massachusetts
            Dana Farber Cancer Institute
          Mar 22, 2022

          Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)

          Completed
          Has Results
          • Kidney Cancer
          • recombinant interferon alfa
          • tretinoin liposome
          • New York, New York
          • +1 more
          Mar 17, 2022

          Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Baltimore (Olaparib)

          Recruiting
          • Renal Cell Carcinoma
          • +4 more
          • Baltimore, Maryland
            Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
          Mar 14, 2022

          Checkpoint Inhibitor Response

          Active, not recruiting
          • NSCLC
          • +4 more
          • Breathprint analysis and patient-reported outcomes
          • Toronto, Ontario, Canada
            Princess Margaret Cancer Centre
          Feb 24, 2022

          Prostate Carcinoma, Kidney Cancer, Urothelial Carcinoma Trial in Helsinki (Personalised treatment)

          Recruiting
          • Prostate Carcinoma
          • +4 more
          • Personalised treatment
          • Helsinki, Uusimaa, Finland
            Helsinki University Hospital
          Mar 10, 2022

          Breast Cancer, Colorectal Cancer, Endometrial Cancer Trial in Birmingham, Memphis (Adapting MultiPLe Behavior Interventions That

          Recruiting
          • Breast Cancer
          • +8 more
          • Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
          • +3 more
          • Birmingham, Alabama
          • +1 more
          Feb 8, 2022

          Observe Onset of Immune-related Adverse Reactions in

          Completed
          • Renal Cell Carcinoma
          • Kidney Cancer
          • Non-Interventional
          • Tokyo, Japan
            Local Institution
          Feb 9, 2022